Trial Profile
Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2022
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary) ; Methylprednisolone (Primary) ; Sulfanilamides
- Indications Pneumocystis pneumonia
- Focus Therapeutic Use
- 11 Mar 2020 Planned number of patients changed from 200 to 60.
- 11 Mar 2020 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2020.
- 13 Jan 2020 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2024.